Bio-Techne announces publication of data demonstrating clinical validation of its EPI test
Bio-Techne announced the online publication of its second prospective US clinical validation study of the Exosome Diagnostics-branded ExoDx® Prostate(IntelliScore) in European Urology [McKiernan J, et al. ExoDx® is the first exosomal urine-based liquid biopsy test. September 18, 2018